Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,827 | 464 | 94.9% |
| Education | $583.04 | 6 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,374 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $679.54 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $654.83 | 35 | $0 (2024) |
| Seagen Inc. | $619.52 | 20 | $0 (2023) |
| Merck Sharp & Dohme LLC | $613.10 | 28 | $0 (2024) |
| Lilly USA, LLC | $535.72 | 21 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $492.14 | 14 | $0 (2024) |
| Amgen Inc. | $463.35 | 20 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $433.66 | 17 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $341.00 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,204 | 92 | Janssen Biotech, Inc. ($390.93) |
| 2023 | $3,398 | 125 | Seagen Inc. ($445.44) |
| 2022 | $3,474 | 142 | E.R. Squibb & Sons, L.L.C. ($349.39) |
| 2021 | $2,334 | 111 | Janssen Biotech, Inc. ($337.14) |
All Payment Transactions
470 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $35.75 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TALVEY, TECVAYLI | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: Oncology | ||||||
| 12/13/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: Hematology/Oncology | ||||||
| 11/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Oncology | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Oncology | ||||||
| 10/28/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $92.46 | General |
| Category: Oncology | ||||||
| 10/24/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/23/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NONE | ||||||
| 10/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/10/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
About Jenny Morrow, NP
Jenny Morrow, NP is a Family healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1275016107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenny Morrow, NP has received a total of $11,410 in payments from pharmaceutical and medical device companies, with $2,204 received in 2024. These payments were reported across 470 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($10,827).
Practice Information
- Specialty Family
- Location Houston, TX
- Active Since 09/06/2018
- Last Updated 09/06/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1275016107
Products in Payments
- IMBRUVICA (Drug) $1,149
- KEYTRUDA (Biological) $551.89
- MYRISK (Device) $372.39
- VERZENIO (Drug) $365.53
- OPDIVO (Biological) $359.09
- Lenvima (Drug) $327.42
- Trodelvy (Drug) $321.44
- DARZALEX (Biological) $308.31
- Pomalyst (Drug) $276.04
- LIBTAYO (Biological) $231.23
- REBLOZYL (Biological) $227.82
- BRUKINSA (Drug) $224.61
- KISQALI (Drug) $216.68
- BLENREP (Biological) $195.70
- ERLEADA (Drug) $189.62
- Kyprolis (Drug) $188.66
- LYNPARZA (Drug) $187.22
- PADCEV (Biological) $183.75
- ADCETRIS (Biological) $155.78
- CABOMETYX (Drug) $142.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Houston
Mrs. Sarah Aguilar, N.p, N.P
Family — Payments: $167,309
Margaret White, Fnp-Bc, FNP-BC
Family — Payments: $71,272
Mrs. Katrina King, Arnp, ARNP
Family — Payments: $43,591
Shaila Khowja, Fnp-C, FNP-C
Family — Payments: $25,332
Kendrick Clack, Fnp-C, FNP-C
Family — Payments: $22,281
Tammy Davis
Family — Payments: $18,660